Zocor® and Amiodarone: A Deadly Combination

A very serious drug interaction exists between Amiodarone and the cholesterol-lowering medication simvastatin, sold under the brand name Zocor®. Amiodarone is a prescription medication used to treat and prevent certain types of serious, life-threatening ventricular arrhythmias. Ventricular arrhythmias are a type of abnormal heart rhythm.

Amiodarone is used when other medications did not help or could not be tolerated by the patient. The use of Amiodarone with high doses of Zocor® may be associated with an increased risk of myopathy and a rare and potentially fatal form of myopathy called rhabdomyolysis.

Myopathy is a muscle disease where the muscle fibers do not function for any number of reasons. Myopathy is usually characterized by unexplained muscle weakness or pain and can be a debilitating condition.

Rhabdomyolysis occurs when damaged skeletal muscle tissue fibers break down and the muscle fibers are released into the bloodstream. The broken down tissue is eliminated from the body through the kidneys. This can cause the kidneys to become overworked resulting in potential kidney failure or death.

FDA Warnings

In 2008 the U.S. Food and Drug Administration (FDA) put out a warning to notify the general public about the increased risk of rhabdomyolysis when simvastatin or Zocor® is used in combination with Amiodarone. According to the agency, the risk is dose-related and increases when the does of Zocor® is higher than 20 mg per day and taken in combination with Amiodarone.

Healthcare professionals should be aware of this risk, and they should avoid prescribing doses of more than 20 mg of Zocor® for patients who also take Amiodarone.

Other Dangerous Drug Interactions

Patients should discuss the other dangerous drug interactions that may occur when taking Zocor® with their doctors. Zocor®'s label was recently updated to include information about all the drugs that might interact with simvastatin. If you are not sure if you should be taking certain medication combinations, be sure to speak with your doctor right away.

If you've experience problems caused by drug interactions that your doctor failed to warn you about, you might be eligible for compensation. Health care providers have a responsibility to inform their patients about these risks. Contact a Zocor® attorney to learn more today.

Contact Us

Schedule a free and confidential case review today.
* is a required field

Miller Legal LLP
700 12th Street, N.W. Suite 700
Washington, DC 20005

Top News

FDA: Zocor Patients Should Understand Rhabdomyolysis Symptoms

October 26th, 2011

High doses of Zocor® (simvastatin) have been linked to an increase in the risk of a serious muscle disease, rhabdomyolysis. Patients... read more

FDA OKs Cholesterol-Diabetes Pill

October 8th, 2011

The U.S. Food and Drug Administration (FDA) on Oct. 7, 2011, approved a combined diabetes-cholesterol drug, according to Bloomberg.

The new pill... read more

FDA Says to Limit High Dosage Zocor

September 22nd, 2011

The U.S. Food and Drug Administration (FDA) published an update warning consumers and health care providers to curtail the use of... read more